{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:16:19Z","timestamp":1771614979840,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T00:00:00Z","timestamp":1501891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"National Natural Science Foundation Project","award":["81200679"],"award-info":[{"award-number":["81200679"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10792-017-0682-4","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T14:54:43Z","timestamp":1501944883000},"page":"1947-1953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Upregulated IRAK1 and IRAK4 promoting the production of IFN-\u03b3 and IL-17 in Behcet\u2019s disease"],"prefix":"10.1007","volume":"38","author":[{"given":"Min","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peizeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,5]]},"reference":[{"issue":"5","key":"682_CR1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0002-9394(01)00925-4","volume":"131","author":"RW Read","year":"2001","unstructured":"Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L et al (2001) Revised diagnostic criteria for Vogt\u2013Koyanagi\u2013Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 131(5):647\u2013652","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"682_CR2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"LE Harrington","year":"2005","unstructured":"Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6(11):1123\u20131132","journal-title":"Nat Immunol"},{"issue":"5252","key":"682_CR3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1126\/science.271.5252.1128","volume":"271","author":"Z Cao","year":"1996","unstructured":"Cao Z, Henzel WJ, Gao X (1996) IRAK: a kinase associated with the interleukin-1 receptor. Science 271(5252):1128\u20131131","journal-title":"Science"},{"issue":"8","key":"682_CR4","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.082100399","volume":"99","author":"S Li","year":"2002","unstructured":"Li S, Strelow A, Fontana EJ, Wesche H (2002) IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A 99(8):5567\u20135572","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"682_CR5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cellsig.2007.08.009","volume":"20","author":"S Gottipati","year":"2008","unstructured":"Gottipati S, Rao NL, Fung-Leung WP (2008) IRAK1: a critical signaling mediator of innate immunity. Cell Signal 20(2):269\u2013276","journal-title":"Cell Signal"},{"issue":"6","key":"682_CR6","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.4049\/jimmunol.170.6.2833","volume":"170","author":"C Deng","year":"2003","unstructured":"Deng C, Radu C, Diab A, Tsen MF, Hussain R, Cowdery JS et al (2003) IL-1 receptor-associated kinase 1 regulates susceptibility to organ-specific autoimmunity. J Immunol 170(6):2833\u20132842","journal-title":"J Immunol"},{"issue":"7","key":"682_CR7","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.189.7.1129","volume":"189","author":"P Kanakaraj","year":"1999","unstructured":"Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, Harris CA et al (1999) Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J Exp Med 189(7):1129\u20131138","journal-title":"J Exp Med"},{"key":"682_CR8","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ejphar.2014.06.013","volume":"740","author":"JJ Jeong","year":"2014","unstructured":"Jeong JJ, Jang SE, Hyam SR, Han MJ, Kim DH (2014) Mangiferin ameliorates colitis by inhibiting IRAK1 phosphorylation in NF-kappaB and MAPK pathways. Eur J Pharmacol 740:652\u2013661","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"682_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.imlet.2012.09.004","volume":"148","author":"P Xia","year":"2012","unstructured":"Xia P, Fang X, Zhang ZH, Huang Q, Yan KX, Kang KF et al (2012) Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett 148(2):151\u2013162","journal-title":"Immunol Lett"},{"issue":"6882","key":"682_CR10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nature736","volume":"416","author":"N Suzuki","year":"2002","unstructured":"Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C et al (2002) Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416(6882):750\u2013756","journal-title":"Nature"},{"issue":"5615","key":"682_CR11","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1126\/science.1081902","volume":"299","author":"C Picard","year":"2003","unstructured":"Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K et al (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299(5615):2076\u20132079","journal-title":"Science"},{"issue":"5","key":"682_CR12","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1084\/jem.20061523","volume":"204","author":"T Kawagoe","year":"2007","unstructured":"Kawagoe T, Sato S, Jung A, Yamamoto M, Matsui K, Kato H et al (2007) Essential role of IRAK-4 protein and its kinase activity in Toll-like receptor-mediated immune responses but not in TCR signaling. J Exp Med 204(5):1013\u20131024","journal-title":"J Exp Med"},{"issue":"2","key":"682_CR13","doi-asserted-by":"crossref","first-page":"312.e4","DOI":"10.1016\/j.ophtha.2007.04.056","volume":"115","author":"P Yang","year":"2008","unstructured":"Yang P, Fang W, Meng Q, Ren Y, Xing L, Kijlstra A (2008) Clinical features of chinese patients with Behcet\u2019s disease. Ophthalmology 115(2):312.e4\u2013318.e4","journal-title":"Ophthalmology"},{"issue":"11","key":"682_CR14","first-page":"3480","volume":"41","author":"MD Smet de","year":"2000","unstructured":"de Smet MD, Dayan M (2000) Prospective determination of T-cell responses to S-antigen in Behcet\u2019s disease patients and controls. Invest Ophthalmol Vis Sci 41(11):3480\u20133484","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"682_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/bjo.77.9.584","volume":"77","author":"JH Yamamoto","year":"1993","unstructured":"Yamamoto JH, Minami M, Inaba G, Masuda K, Mochizuki M (1993) Cellular autoimmunity to retinal specific antigens in patients with Behcet\u2019s disease. Br J Ophthalmol 77(9):584\u2013589","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"682_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/030097402320318387","volume":"31","author":"K Hamzaoui","year":"2002","unstructured":"Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K (2002) Cytokine profile in Behcet\u2019s disease patients. Relationship with disease activity. Scand J Rheumatol 31(4):205\u2013210","journal-title":"Scand J Rheumatol"},{"key":"682_CR17","first-page":"880","volume":"16","author":"W Chi","year":"2010","unstructured":"Chi W, Yang P, Zhu X, Wang Y, Chen L, Huang X et al (2010) Production of interleukin-17 in Behcet\u2019s disease is inhibited by cyclosporin A. Mol Vis 16:880\u2013886","journal-title":"Mol Vis"},{"issue":"4","key":"682_CR18","doi-asserted-by":"crossref","first-page":"e93214","DOI":"10.1371\/journal.pone.0093214","volume":"9","author":"M Sun","year":"2014","unstructured":"Sun M, Yang P, Du L, Yang Y, Ye J (2014) The role of interleukin-1 receptor-associated kinases in Vogt\u2013Koyanagi\u2013Harada disease. PLoS ONE 9(4):e93214","journal-title":"PLoS ONE"},{"issue":"8697","key":"682_CR19","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet\u2019s disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet\u2019s disease (1990) International Study group for Behcet\u2019s disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"issue":"11","key":"682_CR20","doi-asserted-by":"crossref","first-page":"E1529","DOI":"10.3390\/molecules21111529","volume":"21","author":"MC Patra","year":"2016","unstructured":"Patra MC, Choi S (2016) Recent progress in the molecular recognition and therapeutic importance of interleukin-1 receptor-associated kinase 4. Molecules 21(11):E1529","journal-title":"Molecules"},{"issue":"4","key":"682_CR21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.4049\/jimmunol.1600258","volume":"197","author":"J Talreja","year":"2016","unstructured":"Talreja J, Talwar H, Ahmad N, Rastogi R, Samavati L (2016) Dual inhibition of Rip2 and IRAK1\/4 regulates IL-1beta and IL-6 in sarcoidosis alveolar macrophages and peripheral blood mononuclear cells. J Immunol 197(4):1368\u20131378","journal-title":"J Immunol"},{"issue":"3","key":"682_CR22","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yexmp.2007.02.002","volume":"82","author":"SG Lakoski","year":"2007","unstructured":"Lakoski SG, Li L, Langefeld CD, Liu Y, Howard TD, Brosnihan KB et al (2007) The association between innate immunity gene (IRAK1) and C-reactive protein in the diabetes heart study. Exp Mol Pathol 82(3):280\u2013283","journal-title":"Exp Mol Pathol"},{"issue":"2","key":"682_CR23","doi-asserted-by":"crossref","first-page":"H597","DOI":"10.1152\/ajpheart.0655.2001","volume":"285","author":"JA Thomas","year":"2003","unstructured":"Thomas JA, Haudek SB, Koroglu T, Tsen MF, Bryant DD, White DJ et al (2003) IRAK1 deletion disrupts cardiac Toll\/IL-1 signaling and protects against contractile dysfunction. Am J Physiol Heart Circ Physiol 285(2):H597\u2013H606","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"14","key":"682_CR24","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1161\/CIRCULATIONAHA.113.002275","volume":"128","author":"A Valaperti","year":"2013","unstructured":"Valaperti A, Nishii M, Liu Y, Naito K, Chan M, Zhang L et al (2013) Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production. Circulation 128(14):1542\u20131554","journal-title":"Circulation"},{"issue":"Suppl 1","key":"682_CR25","first-page":"S53","volume":"3","author":"H Yazici","year":"2004","unstructured":"Yazici H (2004) The lumps and bumps of Behcet\u2019s syndrome. Autoimmun Rev 3(Suppl 1):S53\u2013S54","journal-title":"Autoimmun Rev"},{"issue":"2","key":"682_CR26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0181-5512(06)73762-7","volume":"29","author":"H Guenane","year":"2006","unstructured":"Guenane H, Hartani D, Chachoua L, Lahlou-Boukoffa OS, Mazari F, Touil-Boukoffa C (2006) Production of Th1\/Th2 cytokines and nitric oxide in Behcet\u2019s uveitis and idiopathic uveitis. J Fr Ophtalmol 29(2):146\u2013152","journal-title":"J Fr Ophtalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-017-0682-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-017-0682-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T18:28:18Z","timestamp":1536949698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-017-0682-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1007\/s10792-017-0682-4","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,5]]}}}